|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-14
|
$3,769,923
|
$753,985
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-03
|
$3,469,664
|
$728,629
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
TCR Gene Modified T Cells for Adoptive Immunotherapy
|
5P01CA154778-04
|
$3,295,681
|
$1,812,625
|
NISHIMURA, MICHAEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Stem Cell-Engineered Tumor Immunity in Man
|
5P01CA132681-05
|
$2,795,193
|
$2,431,818
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Texas Center for Cancer Nanomedicine
|
5U54CA151668-05
|
$2,695,386
|
$1,132,062
|
GORENSTEIN, DAVID
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$2,555,132
|
$1,022,053
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$2,555,132
|
$1,022,053
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Carolina Center of Cancer Nanotechnology Excellence
|
5U54CA151652-05
|
$2,415,854
|
$265,744
|
DESIMONE, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Center for Translational Cancer Nanomedicine
|
5U54CA151881-05
|
$2,407,041
|
$433,267
|
TORCHILIN, VLADIMIR
|
NORTHEASTERN UNIVERSITY
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-05
|
$2,357,460
|
$612,940
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
MIT-Harvard Center of Cancer Nanotechnology Excellence
|
5U54CA151884-05
|
$2,212,567
|
$376,136
|
LANGER, ROBERT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
SPORE in Lymphoma
|
5P50CA126752-08
|
$2,162,000
|
$518,880
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
1P50CA186784-01
|
$2,162,000
|
$129,720
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Duke SPORE in Brain Cancer
|
1P50CA190991-01
|
$2,162,000
|
$86,480
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
SPORE in Cervical Cancer
|
2P50CA098252-11
|
$2,162,000
|
$237,820
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
M.D. Anderson Gynecologic SPORE for Uterine Cancers
|
5P50CA098258-10
|
$2,162,000
|
$86,480
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Skin Cancer
|
1P50CA174523-01A1
|
$2,162,000
|
$86,480
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
SPORE: Brain Tumore SPORE Grant
|
5P50CA097257-12
|
$2,161,996
|
$108,100
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Seattle Cancer Consortium Breast SPORE
|
5P50CA138293-05
|
$2,150,779
|
$172,062
|
PORTER, PEGGY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-10
|
$2,133,882
|
$128,033
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-15
|
$2,093,826
|
$251,259
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-13
|
$1,910,079
|
$191,008
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE In Prostate Cancer
|
5P50CA092629-14
|
$1,881,400
|
$206,954
|
SCHER, HOWARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-12
|
$1,874,319
|
$937,160
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-15
|
$1,847,930
|
$240,231
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
2P01CA078902-16
|
$1,846,366
|
$867,792
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
1P01CA177322-01A1
|
$1,732,435
|
$138,595
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-14
|
$1,455,670
|
$378,474
|
LARSON, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-15
|
$1,392,802
|
$55,712
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Telomere Biology
|
ZIA BC 011519
|
$1,321,954
|
$26,439
|
Cooper, Julia
|
CCR (NCI)
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-14
|
$1,264,315
|
$75,859
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
|
5P01CA066726-17
|
$1,147,325
|
$321,251
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,023,345
|
$255,836
|
Court, Donald
|
CCR (NCI)
|
|
EGFR-targeted siRNA nanoparticles to treat NSCLC
|
N43CO130030-007
|
$1,000,000
|
$1,000,000
|
UNGER, GRETCHEN
|
GENESEGUES INC
|
|
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
|
5U54CA163167-04
|
$934,250
|
$102,768
|
HOLLAND, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$831,862
|
$124,779
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$812,963
|
$406,481
|
Somerville, Robert
|
CCR (NCI)
|
|
Cell Prep Core
|
ZIC BC 010905
|
$812,963
|
$406,481
|
Wunderlich, John
|
CCR (NCI)
|
|
Clinical Trials of Immunotherapies for Childhood Cancer
|
ZIA BC 011498
|
$776,987
|
$310,795
|
Mackall, Crystal
|
CCR (NCI)
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-30
|
$617,613
|
$617,613
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$613,610
|
$184,083
|
Fry, Terry
|
CCR (NCI)
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
2R01CA136551-06A1
|
$579,424
|
$289,712
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
1R01CA183296-01A1
|
$576,204
|
$288,102
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY
|
5R01CA163587-03
|
$564,591
|
$282,296
|
COOPER, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Mechanisms of Murine Turmor Eradication by Immunotherapy
|
5R01CA033084-31
|
$521,765
|
$521,765
|
GREENBERG, PHILIP
|
UNIVERSITY OF WASHINGTON
|
|
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
|
1R01CA178397-01A1
|
$504,278
|
$166,412
|
O'HARE, THOMAS
|
UNIVERSITY OF UTAH
|
|
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
|
1R01CA168712-01A1
|
$504,056
|
$504,056
|
KELLY, KIMBERLY
|
UNIVERSITY OF VIRGINIA
|
|
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer
|
ZIA BC 011566
|
$497,942
|
$149,383
|
Gu, Shuo
|
CCR (NCI)
|
|
Molecular Basis of Parvoviral Target Cell Specificity
|
5R01CA029303-33
|
$474,706
|
$118,677
|
TATTERSALL, PETER
|
YALE UNIVERSITY
|
|
UCLA Tumor Immunology Training Program
|
5T32CA009120-38
|
$467,412
|
$93,482
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Gene Therapy for this search: $46,781,139
|